Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain

Stopped early · Phase 4

Conditions studied: Moderate-severe Pain

In brief

Safety and pharmacokinetics of an abuse-deterrent, extended-release formulation of morphine sulfate with a sequestered naltrexone core in children 7-17 with moderate-severe pain.

Key facts

Study ID
NCT02101554
Run by
Pfizer
People needed
19
Starts
2015-04-24
Expected to finish
2019-06-26
Last updated by the study team
2020-07-10

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.